EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Frequency and correlates of subjective cognitive complaints and objective cognitive screening results in African American adults following COVID-19 infection

Felicia C Goldstein, Ihab Hajjar, Aerica Summers, Alexander D Truong, F Frances Eun-Hyung Lee, Jenny E Han, Tiffany A Walker

Brain, Behavior, & Immunity - Health · 2023-12 · 34 · 100691

DOI: 10.1016/j.bbih.2023.100691 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, Behavior, & Immunity - Health, 2023-12. Verfasst von Felicia C Goldstein und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hearst Foundations.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Subjective cognitive complaints are frequent following COVID-19 infection, but assessment of whether these complaints map onto objective cognitive findings may not be routine in busy clinical settings. Consequently, opportunities to confirm these complaints and to provide follow-up referrals and appropriate care may be missed, thereby impacting patients' functional independence and quality of life. African Americans are vulnerable to poor outcomes from COVID-19, and thus represent a minority group in whom subjective concerns are especially important to investigate. Towards this end, we examined the frequency and correlates of subjective complaints and objective screening results of African American patients referred to the Post-Acute Sequelae of SARS-CoV-2 (PASC) Clinic at Grady Memorial Hospital, a large county teaching hospital in Atlanta, Georgia.

Methods

Eighty seven African American patients (mean age = 52.5, SD = 10.5, range = 30-73) were evaluated between January 28, 2021-October 14, 2021 in the Grady PASC clinic. They ranged from 1 to 17 months post positive SARS-COV-2 antigen testing. Patients were administered a subjective cognitive complaint questionnaire (PROMIS Cognitive Function Scale Short Form 8a) as well as cognitive screening measures including the Mini-Cog (3 item recall, clock) and the Digit Symbol Substitution Test (timed visuomotor sequencing). Mood was assessed via the Patient Health Questionnaire-9, and anxiety via the Generalized Anxiety Disorders Scale. Published norms were used to identify clinically elevated scores.

Results

Sixty six (76%) patients denied experiencing meaningful cognitive concerns, and of these, 25 (38%) had positive cognitive screens indicating impaired performance on objective testing. Of 21 patients with subjectively elevated cognitive concerns, 17 (81%) also had positive cognitive screens. There were no significant differences in sociodemographic factors (p values = .07-.71), days post-acute positive SARS-COV-2 Antigen Test (p = .99), disease severity (p values = .67-.75), or COVID-19 comorbidity indices (medical conditions (p values = .20-.77), substance abuse (p = .79), psychiatric history (p values = .11-.99) in those with or without subjective complaints and objective cognitive findings. However, patients with subjective complaints and objective cognitive findings reported more post-COVID-19 anxiety (p = .02) and depression (p = .001).

Conclusions

Findings indicate a high concordance between subjective complaints on the PROMIS Cognitive Scale and objectively confirmed cognitive impairments in African Americans. Further, almost 40% who reported no cognitive complaints screened positive for cognitive impairment. Although depression and anxiety are associated with subjective complaints, they do not account for positive cognitive screening results, as those patients without depressive complaints also had similar rates of positive objective screens. The findings suggest that cognitive screening using assessment tools should be routinely performed in African Americans, especially those reporting cognitive symptoms on outcome scales. While future studies are needed to assess long-term outcomes, we highly recommend follow-ups in those with positive screens to characterize the specific domains that are impacted and that could affect activities of daily living and quality of life.

Schlagwörter

Stichwörter der Autor:innen

AnxietyCognitive impairmentCognitive screeningCovid-19DepressionSubjective cognitive complaints

Autor:innen und Institutionen

  • Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA.
  • Department of Neurology, University of Texas Southwestern, Dallas, TX, USA.
  • Grady Post-COVID Clinic, Grady Memorial Hospital, Atlanta, GA, USA.
  • Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Department of Medicine, Division of General Internal Medicine, Emory University School of Medicine, Atlanta, GA, USA.

Förderung

  • Hearst Foundations

Zitieren

APA

Goldstein, F. C., Hajjar, I., Summers, A., Truong, A. D., Lee, F. F. E., Han, J. E., & Walker, T. A. (2023). Frequency and correlates of subjective cognitive complaints and objective cognitive screening results in African American adults following COVID-19 infection. Brain, Behavior, & Immunity - Health, 34, 100691. https://doi.org/10.1016/j.bbih.2023.100691

Vancouver

Goldstein FC, Hajjar I, Summers A, Truong AD, Lee FFE, Han JE, et al. Frequency and correlates of subjective cognitive complaints and objective cognitive screening results in African American adults following COVID-19 infection. Brain, Behavior, & Immunity - Health. 2023;34:100691. doi:10.1016/j.bbih.2023.100691

BibTeX
@article{Goldstein2023,
  author = {Goldstein, Felicia C and Hajjar, Ihab and Summers, Aerica and Truong, Alexander D and Lee, F Frances Eun-Hyung and Han, Jenny E and Walker, Tiffany A},
  title = {Frequency and correlates of subjective cognitive complaints and objective cognitive screening results in African American adults following COVID-19 infection},
  journal = {Brain, Behavior, & Immunity - Health},
  year = {2023},
  volume = {34},
  pages = {100691},
  doi = {10.1016/j.bbih.2023.100691}
}
Kostenlos starten →